ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,710, issued on May 6, was assigned to Nippon Shinyaku Co. Ltd. (Kyoto, Japan) and Niigata University (Niigata, Japan).
"Antisense oligonucleotide targeting ATN1 mRNA or pre-mRNA" was invented by Takao Kawano (Kyoto, Japan), Toshiaki Ode (Kyoto, Japan), Akie Chiba (Ibaraki, Japan), Osamu Onodera (Niigata, Japan), Taisuke Kato (Niigata, Japan) and Sachiko Hirokawa (Niigata, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an antisense oligonucleotide that is formed of 15-22 nucleotides and that is complementary to a nucleic acid including at least 15 consecutive bases in a specific target region of a base sequence of...